Downregulation of NOTCH1 by hsa-mir-200c/mir-141 may also sensitize tumors to methotrexate thus suggesting potential chemotherapeutic options for bladder cancer subjects. The gene discussed is NOTCH1; the disease is urinary bladder carcinoma.